CrossrefInfokarte
Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Clinical Drug Investigation · 2025-05 · 45 (5) · 235-245
DOI: 10.1007/s40261-025-01436-9 ↗Abstract
Kein Abstract verfügbar.
EUVIMED